In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Kuenzel, Associate Director in the Functional Genomics department at AstraZeneca about the application of arrayed CRISPR screening for target identification and more.
Rare gene mutations in hereditary Alzheimer’s disease disrupt amyloid production, study shows
A University of Kansas study of rare gene mutations that cause hereditary Alzheimer’s disease shows these mutations disrupt production of a small sticky protein called
February 29, 2024